These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8554003)

  • 1. Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors.
    Panina G; Khot UN; Nunziata E; Cody RJ; Binkley PF
    Am Heart J; 1996 Jan; 131(1):153-7. PubMed ID: 8554003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability.
    Panina G; Khot UN; Nunziata E; Cody RJ; Binkley PF
    Am Heart J; 1995 Apr; 129(4):748-53. PubMed ID: 7900627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.
    Binkley PF; Haas GJ; Starling RC; Nunziata E; Hatton PA; Leier CV; Cody RJ
    J Am Coll Cardiol; 1993 Mar; 21(3):655-61. PubMed ID: 8436747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
    Szabó BM; van Veldhuisen DJ; van der Burgh PH; Kruik J; Girbes AR; Lie KI
    J Card Fail; 1996 Sep; 2(3):185-92. PubMed ID: 8891856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability.
    Scalvini S; Volterrani M; Zanelli E; Pagani M; Mazzuero G; Coats AJ; Giordano A
    Int J Cardiol; 1998 Nov; 67(1):9-17. PubMed ID: 9880196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure.
    Vacek JL; Handlin LR; Beaufort CJ; Koenig CA
    Coron Artery Dis; 1993 Dec; 4(12):1109-13. PubMed ID: 8162243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart rate variability in chronic cardiac failure insufficiency. Effect of severity and etiology].
    Gibelin P; Dadoun-Dybal M; Morand P
    Arch Mal Coeur Vaiss; 1994 Sep; 87(9):1207-11. PubMed ID: 7646235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate variability in dilated cardiomyopathy.
    Biswas PK; Basu S; Mitra KK; Chowdhury SP; Chatterjee BP; Das Biswas A; Chatterjee SS; Maity AK
    Indian Heart J; 2000; 52(2):187-91. PubMed ID: 10893896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of digitoxin versus trichlormethiazide/amiloride in congestive heart failure NYHA class II/III and sinus rhythm.
    Huonker M; Sorichter S; Schmidt-Trucksäss A; Irmer M; Staiger J; Keul J
    Cardiovasc Drugs Ther; 1999 May; 13(3):233-41. PubMed ID: 10439886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure.
    Eaton GM; Cody RJ; Nunziata E; Binkley PF
    Circulation; 1995 Aug; 92(3):555-61. PubMed ID: 7634470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy and prognostic value of heart rate variability in 24-hour and short time recordings for determining cardiac autonomic dysfunction in congestive heart failure].
    Tekiner F; Gemici K; Emrecan B; Tekiner E; Jordan J
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):118-23. PubMed ID: 17513204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease.
    Casolo GC; Stroder P; Sulla A; Chelucci A; Freni A; Zerauschek M
    Eur Heart J; 1995 Mar; 16(3):360-7. PubMed ID: 7789379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure.
    Fei L; Keeling PJ; Gill JS; Bashir Y; Statters DJ; Poloniecki J; McKenna WJ; Camm AJ
    Br Heart J; 1994 Apr; 71(4):322-8. PubMed ID: 8198881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration.
    Binkley PF; Nunziata E; Cody RJ
    Am Heart J; 1994 Dec; 128(6 Pt 1):1147-56. PubMed ID: 7985595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased heart rate variability in patients with congestive heart failure and chronotropic incompetence.
    Fei L; Keeling PJ; Sadoul N; Copie X; Malik M; McKenna WJ; Camm AJ
    Pacing Clin Electrophysiol; 1996 Apr; 19(4 Pt 1):477-83. PubMed ID: 8848396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
    Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
    J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y; Guntekin U; Tuncer M; Sahin M
    Arq Bras Cardiol; 2009 Aug; 93(2):154-8. PubMed ID: 19838493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.